KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Repurchased
Ratios

Pacira BioSciences (PCRX) Long-Term Debt Repayments (2016 - 2025)

Historic Long-Term Debt Repayments for Pacira BioSciences (PCRX) over the last 8 years, with Q3 2025 value amounting to $202.5 million.

  • Pacira BioSciences' Long-Term Debt Repayments changed N/A to $202.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $202.5 million, marking a year-over-year change of. This contributed to the annual value of $191.0 million for FY2024, which is N/A changed from last year.
  • Per Pacira BioSciences' latest filing, its Long-Term Debt Repayments stood at $202.5 million for Q3 2025.
  • In the past 5 years, Pacira BioSciences' Long-Term Debt Repayments registered a high of $202.5 million during Q3 2025, and its lowest value of $192.6 million during Q1 2022.